← Browse by Condition
Medical Condition
myocardial infarction
Total Trials
11
Recruiting Now
11
Trial Phases
Phase 2, Phase 3, Phase 4
ClinicalMetric tracks all active clinical trials for myocardial infarction sourced from ClinicalTrials.gov. Research in this area spans early-phase safety investigations through large Phase 3 confirmatory trials, conducted by NIH-funded academic centers, independent investigators, and pharmaceutical sponsors worldwide. Each listing is updated daily as new studies open enrollment and existing ones reach capacity or complete follow-up.
Trial listings include the NCT identifier, current recruitment status, phase classification, primary and secondary endpoints, estimated enrollment size, participating countries, and direct links to the full protocol on ClinicalTrials.gov. Eligibility criteria — including age range, disease stage, and prior treatment requirements — are documented for every study to help patients and clinicians assess suitability before contacting a trial site.
Frequently Asked Questions — myocardial infarction Clinical Trials
How many clinical trials are currently recruiting for myocardial infarction?
ClinicalMetric currently tracks 11 actively recruiting clinical trials for myocardial infarction, sourced in real time from ClinicalTrials.gov. The total number of registered studies—including those not yet enrolling or in active follow-up—is 11. Trial availability changes daily as new studies open enrollment and existing ones reach capacity.
What trial phases are available for myocardial infarction?
myocardial infarction research spans Phase 2 (1 trial), Phase 3 (1 trial), Phase 4 (1 trial). Phase 1 studies evaluate safety and dosing in small groups, Phase 2 studies assess preliminary efficacy in 100–300 participants, and Phase 3 trials compare the new treatment against the standard of care in 300–3,000+ patients. Phase 4 post-approval studies monitor long-term outcomes in real-world populations.
How do I find out if I qualify for a myocardial infarction clinical trial?
Eligibility criteria for myocardial infarction trials vary by study and typically specify age range, disease stage or severity, prior treatment history, and specific diagnostic or laboratory parameters. Each listing on ClinicalMetric links to the full protocol on ClinicalTrials.gov, where inclusion and exclusion criteria are documented. Contact the sponsoring site's research coordinator directly to confirm your eligibility—your treating physician or specialist can also help identify the most appropriate trial based on your medical history and current treatment status.
Trial Phases
Phase 2 1
Phase 3 1
Phase 4 1
Top Sponsors
1 trial
1 trial
1 trial
1 trial
1 trial
Recruiting Clinical Trials
NCT07696390
Recruiting
Enrollment
50 pts
Location
Turkey (Türkiye)
Sponsor
Yuzuncu Yil University
NCT06286878 Phase 2, Phase 3
Recruiting
Enrollment
80 pts
Location
Brazil
Sponsor
University of Sao Paulo
NCT05262803 Phase 4
Recruiting
Enrollment
2,808 pts
Location
Denmark
Sponsor
Rikke Sorensen
NCT02762162
Recruiting
Enrollment
5,000 pts
Location
France
Sponsor
Action, France
NCT06227754
Recruiting
Enrollment
1,500 pts
Location
South Korea
Sponsor
Chonnam National University Ho...
NCT04321512
Recruiting
Enrollment
300 pts
Location
United States
Sponsor
UConn Health
NCT05920629
Recruiting
Enrollment
220 pts
Location
Switzerland
Sponsor
Baris Gencer
NCT05111288
Recruiting
Enrollment
120 pts
Location
United States
Sponsor
Mayo Clinic
NCT06113510
Recruiting
Enrollment
80 pts
Location
United Kingdom
Sponsor
University of Edinburgh
NCT07138911
Recruiting
Enrollment
88 pts
Location
Pakistan
Sponsor
Riphah International Universit...
NCT04178434
Recruiting
Enrollment
64 pts
Location
Sweden
Sponsor
Per Tornvall
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: November 2026 · Data Methodology